Mental Health and Total Wellbeing Education Leader Continues to Diversify and Deepen Capabilities with Acquisition of Boston-Based Provider of On-Demand...
Reported income from operations of $263,000HACKENSACK, NJ / ACCESSWIRE / December 13, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading...
LOS ANGELES, CA / ACCESSWIRE / December 13, 2021 / The number of women in the United States alone who...
The Great Resignation Shows American Workers Need Better Mental Health AccessSAN DIEGO, CA / ACCESSWIRE / December 13, 2021 /...
Leading Formulary Management, Drug Safety Information Provider Improves Healthcare Worker Safety by Providing Vital Safety Guidance In EHR, On Any...
The recognition of Orphan Drug Designation in Europe for crofelemer for this rare disease is the first key milestone of...
Kai Medical Laboratory to Provide Over 6,000 Rapid Antigen and PCR COVID-19 TestsVANCOUVER, BC / ACCESSWIRE / December 13, 2021...
Pivotal clinical trial will begin in first half of 2022ENGLEWOOD, CO / ACCESSWIRE / December 13, 2021 / Aytu BioPharma,...
JACKSON CENTER, PA / ACCESSWIRE / December 13, 2021 / Halberd Corporation (OTC PINK:HALB) has demonstrated 100% eradication of Interleukin-1...
Teams up with OK2Roam and VFS Global to streamline COVID-19 testing protocols for travelers from Canada and the U.S.TORONTO, ON...
ORLANDO, FL / ACCESSWIRE / December 13, 2021 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of pharmaceutical...
Investigational New Drug Application for Study of MTX110 in Recurrent Glioblastoma (GBM) Becomes EffectiveABINGDON, OXFORDSHIRE / ACCESSWIRE / December 13,...
- Preclinical data demonstrates complete functionality of SENTI-202 OR+NOT Logic Gated gene circuits for the elimination of AML cancer cells...
Keros Therapeutics will be hosting a conference call and webcast today, December 13, 2021, at 4:01 p.m. ET.LEXINGTON, Mass., Dec....
6 of 10 Patients Naïve to Treatment with Autologous CAR T-cell Therapy Continue in Ongoing Response at Median Follow-up of...
B-AMAZE long-term follow up data demonstrate sustained FIX expression up to 3.5 years; potential for expression levels in the normal...
Data Presented in Poster Presentation at American Society of Hematology Annual MeetingBURLINGAME, Calif., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Corvus...
BRISBANE, Calif., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class...
95% overall response rate, 65% complete response rate and favorable safety profile in patients treated with modified cell manufacturing process Data presented at the 63rd...
-- Two dose levels studied (100 and 300 million CAR+ T-cells); MTD not reached -- -- 100% ORR at both...